Skip to Content

Itoco Inc ITMC

Morningstar Rating
$0.01 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ITMC is trading at a 469% premium.
Price
$0.01
Fair Value
$3.69
Uncertainty
Extreme
1-Star Price
$8.12
5-Star Price
$7.54
Economic Moat
Ywdh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ITMC is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.010.01
52-Week Range
$0.000.04
Bid/Ask
$0.01 / $0.01
Market Cap
$239.07
Volume/Avg
10,000 / 28,365

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Itoco Inc is focused on developing and bringing biotech products to the market via co-development and joint venture arrangements with various companies. The company is currently examining various technologies that seek to control and/or identify bio-contaminants such as viruses and bacteria.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
47

Valuation

Metric
ITMC
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ITMC
Quick Ratio
0.03
Current Ratio
0.18
Interest Coverage
−5.37
Quick Ratio
No chart available

Profitability

Metric
ITMC
Return on Assets (Normalized)
−118.92%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRZhrzbjpwBqs$605.7 Bil
VRTX
Vertex Pharmaceuticals IncNybjvjxyKzxflv$116.3 Bil
REGN
Regeneron Pharmaceuticals IncSjfhjvhdWrqkvwk$108.5 Bil
MRNA
Moderna IncMxkvbbcRjv$62.9 Bil
BNTX
BioNTech SE ADRZvwhkwjLpmv$23.9 Bil
ARGX
argenx SE ADRSvfftvbCdvx$21.6 Bil
ALNY
Alnylam Pharmaceuticals IncLnqcfhscHhlzyzg$18.9 Bil
BMRN
Biomarin Pharmaceutical IncScwmscbBrnkx$14.3 Bil
INCY
Incyte CorpHfcjcxfSwlmbf$12.9 Bil
UTHR
United Therapeutics CorpDgkyjfxgPmxx$12.1 Bil

Sponsor Center